NicotinamideÀÇ Åõ¿©°¡ ÀϽÃÀûÀÎ ±¹¼ÒÇãÇ÷·Î À¯¹ßµÈ ÈòÁãÀÇ ³ú°æ»ö¿¡ ¹ÌÄ¡´Â ¿µÇâ
Nicotinamide Reduces the Infarct Volume in a Rat Model of Transient Middle Cerebral Artery Occlusion
À̹μ·, ¾È¿µÁØ, ÃÖ±â¿ë, °±¸, Á¤ÀÏ¿µ, ±è±Ù¿ì, °¼º½Ä, ÀÌ°ÇÀç,
¼Ò¼Ó »ó¼¼Á¤º¸
À̹μ· ( Lee Min-Sup )
°¿ø´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¾È¿µÁØ ( Ahn Young-Jun )
°¿ø´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÃÖ±â¿ë ( Choi Ki-Young )
°¿ø´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
°±¸ ( Kang Gu )
°¿ø´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
Á¤ÀÏ¿µ ( Cheong Il-Young )
°¿ø´ëÇб³º´¿ø ÀÓ»óÀÇÇבּ¸¼Ò
±è±Ù¿ì ( Kim Keun-Woo )
°¿ø´ëÇб³º´¿ø ÀÓ»óÀÇÇבּ¸¼Ò
°¼º½Ä ( Kang Seong-Sik )
°¿ø´ëÇб³º´¿ø ÀÓ»óÀÇÇבּ¸¼Ò
ÀÌ°ÇÀç ( Lee Kun-Jai )
°¿ø´ëÇб³º´¿ø ÀÓ»óÀÇÇבּ¸¼Ò
KMID : 0357920060400020093
Abstract
Background: Cerebral ischemia depletes ATP and causes irreversible tissue injury. Nicotinamide is a precursor of NAD+ and it is also a poly (ADP-ribose) polymerase (PARP) inhibitor that increases the neuronal ATP concentration and so protects against stroke. Therefore we examined whether nicotinamide could protect against cerebral ischemia by using a model of transient middle cerebral artery occlusion (MCAO) (reperfusion 2 h post ischemia) in Sprague-Dawley rats.
Methods: Nicotinamide (500 mg/kg) or normal saline was administered intraperitoneally 24 and 0 h before and after MCAO, respectively. The infarction volumes were determined with triphenyltetrazolium chloride staining 24 h after reperfusion. The nitrotyrosine, PAR polymer and PARP-1 expressions were examined by immunohistochemistry with using brain slices obtained from the rats that were sacrificed at 0, 15, 30, 60 and 120 min after reperfusion.
Results: The infarction volumes were significantly attenuated (21.8%, p<0.05). The nitrotyrosine expressions were increased at 0, 15 and 30 min, and those expressions for PARP polymer and PARP-1 were increased at 60 and 120 min, respectively. Nicotinamide partly reduced the expressions for nitrotyrosine and PAR polymer except for PARP-1.
Conclusions: These results suggest that nicotinamide may attenuate ischemic brain injury through its antioxidant activity and the inhibition of PARP-1.
Å°¿öµå
Nicotinamide;PARP-1;Nitrotyrosine;Brain ischemia
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸